brusatol has been researched along with Head and Neck Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahn, KS; Lee, JH; Lin, ZX; Mohan, CD; Rangappa, KS; Rangappa, S; Sethi, G | 1 |
1 other study(ies) available for brusatol and Head and Neck Neoplasms
Article | Year |
---|---|
Brusatol, a Nrf2 Inhibitor Targets STAT3 Signaling Cascade in Head and Neck Squamous Cell Carcinoma.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Quassins; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; STAT3 Transcription Factor | 2019 |